Jing Lim
Follow
Get notifications in MyBN when activity occurs.
Jing Lim
Chief Technology Officer, Chief Executive since 2023 / Osteopore
Dr Jing Lim joined Osteopore in November 2014 as a product development engineer before becoming product development manager in July 2015, chief technology officer in 2018, chief operating officer in 2022, and chief executive in July 2023. Dr Lim played a key role in the company reaching its key regulatory and quality milestones, including compliance with the European Union’s Medical Device Regulation. He also spearheaded a successful A$19m project with the National Dental Centre and A*Star.
In 2022, Dr Lim was recognised by Pharma Intelligence as one of 30 people to watch across the biopharma, med-tech and health-tech sectors in Vivo’s Rising Leaders.
He holds a PhD from Nanyang Technology University, Singapore.
In 2022, Dr Lim was recognised by Pharma Intelligence as one of 30 people to watch across the biopharma, med-tech and health-tech sectors in Vivo’s Rising Leaders.
He holds a PhD from Nanyang Technology University, Singapore.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1810th | Osteopore | -76% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Osteopore | $2.4m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Technology Officer, Chief Executive since 2023, Osteopore | 19 Jul 2023 |
| NEWS: Tagged in Keenan appointed to Osteopore board | 19 Jul 2023 |
| NEW ROLE: Chief Operating Officer, Osteopore | 24 Nov 2020 |
